Jan 29, 2018
Pyridostigmine treatment reverses pediatric complications of botulinum toxin therapy
Report suggests a drug for myasthenia gravis can also quickly and safely reverse complications from botulinum toxin therapy in pediatric patients.
Oct 30, 2017
Umbilical cord blood improves motor skills in some children with cerebral palsy
Clinical trial shows improved motor function in children infused with own cells.
Aug 03, 2017
Most newborns with epilepsy benefit from genetic testing
Research published in Neurology analyzed data from the Neonatal Seizure Registry that includes enrollees from 7 children's hospitals. It found that most newborns with epilepsy would benefit from genetic testing because the majority of cases are linked to identifiable genetic causes.
Feb 09, 2017
Gene variant identified for Kawasaki disease susceptibility
Researchers have conducted novel whole genome sequencing of a family in which 2 of 4 children were affected by Kawasaki disease, and have identified plausible gene variants that predispose some children to developing the disease. The findings are published in the PLOS ONE.
Dec 13, 2016
Research identifies a molecular basis for common congenital brain defect
Scientists have discovered a molecular cause of hydrocephalus. Because the same molecule is also implicated in Down syndrome, the finding, published today in the Journal of Neuroscience, may explain the 10-fold increased risk of hydrocephalus in infants born with Down syndrome.
Aug 16, 2016
Most physicians recognize shaken baby syndrome as a medical diagnosis
A University of Colorado School of Medicine researcher and colleagues have conducted the first-ever survey of physicians on the validity of "abusive head trauma" as a medical diagnosis, due to recent controversy on the subject. The survey results provide empiric data that clearly support the conclusion that shaken baby syndrome and abusive head trauma are generally accepted as valid medical diagnoses by a broad range of medical specialists.
Aug 05, 2016
Microcephaly discoveries made in non-Zika cases help explain abnormal brain growth
In 2 new papers in the American Journal of Human Genetics, researchers report new findings about a key protein - CIT - involved in the process that generates the many new cells required to build a normal size brain. Though the new studies didn't involve Zika-related microcephaly, they may provide clues that other scientists can use to investigate how Zika virus disrupts brain development, and my also provide insight into what is required for brains to develop normally.